Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC) announced in a press release today that its shareholders approved its combination with biotech company Humacyte, Inc. (“Humacyte”) at a special meeting earlier this morning. The press release did not include redemption details, but AHAC was able to trade above $10 throughout its redemption deadline August 20, and opened today
Read More